CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 424B5 Offering Prospectus
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- 424B4 Offering Prospectus
- 4/A Shares withheld for taxes Chief Operating Officer gave up 59 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 59 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 51 shares (to pay taxes)
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 4 of 32 · 633 filings